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ABSTRACT 
Pediatric Acute Liver Failure (PALF) is a clinical syndrome in which the affected children lose 
hepatic function and become critically ill within days.  The causes of PALF remain 
indeterminate for about half of the cases. Liver transplantation is a lifesaving procedure but has 
long term adverse effects. It is critical to advance clinical insight by distinguishing patients who  
die without liver transplantation from those who are able to survive without transplantation. The 
PALF study is a multicenter study for children under 18 years old who present with acute liver 
failure. The study collected clinical and laboratory data for the first 7 days or until one of the 
events: death, transplantation or discharge occurred within 7 days following study enrollment. 
Growth Mixture Modeling (GMM) was applied to detect the trajectory patterns of INR 
(International Normalized Ratio) for hepatic-based coagulation through the first 7 days. 
       Three subgroups were identified by INR trajectories with 10.3% classified as high-INR, 
34.7% as middle-INR and 55.0% as low-INR.  The children with an indeterminate diagnosis 
were more likely to be classified into the high-INR group (p<0.0001) than were children with a 
specific diagnosis.   The mortality without liver transplantation within 21 days of study entry was 
similar between the children in the high-INR group (19%) and in the middle-INR group (17%), 
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(p=0.70). The percentage of participants having liver transplantation was significantly higher 
among the children in the high-INR group (61%) than those in the middle-INR group (46%), 
(p=0.01). 
       INR is used as a biomarker for determining the need of liver transplantation.  Children with 
an indeterminate diagnosis were more likely to be in the high-INR group, and more likely to 
undergo liver transplantation as compared to other children with a specified diagnosis.  The 
results suggest that INR was not a strong indicator for death without liver transplantation.  
Further studies should attempt to reveal biological mechanisms among the indeterminate 
diagnosis patients. This study has public health significance for its design to better understand 
the mechanism and progression of the children with acute liver failure from a multi-center 
collaboration.   
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1.0    INTRODUCTION 
1.1 PEDIATRIC ACUTE LIVER FAILURE (PALF) 
Acute liver failure (ALF) is a dramatic clinical syndrome in which previously healthy people 
lose hepatic function and become critically ill within days. It is a life-threatening illness of 
multiple etiologies, unusual severity and a rapid clinical course. A variety of infectious, 
metabolic, cardiovascular and drug-induced causes for ALF have been identified (1).  However, 
the cause of pediatric ALF remains unknown (termed indeterminate) for about half of the cases 
(1). Due to the unknown etiology for the indeterminate children, it is difficult to determine 
treatment strategies. This may be due to lack of insight to clinical development, including the 
probability of recovery without liver transplantation. Children with an indeterminate diagnosis 
have greater probability of receiving liver transplantation than children with a specified etiology 
(1). Although liver transplantation is a lifesaving procedure for children with PALF, given a 
shortage of available organs, many die prior to undergoing a liver transplant action. Of patients 
with ALF who received liver transplantation, long-term survival is diminished in comparison to 
those who received liver transplantation for Wilson’s or other chronic cases (2). Also, as some 
children spontaneously recover while awaiting a liver transplantation, it is possible that some 
children undergo transplantation who would have recovered without transplantation. With the 
current shortage of donor livers, and long term adverse sequelae of liver transplantation, it is 
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critical to discover methods to identify those children who have a high likelihood to survive 
without transplantation and those who are unlikely to survive without transplantation. 
1.2 THE PEDIATRIC ACUTE LIVER FAILURE (PALF) STUDY 
The Pediatric Acute Liver Failure (PALF) study is a multinational collaborative study of infants, 
children and adolescents less than 18 years old who presented with ALF at one of the 
participating centers (1). The PALF was formed to facilitate an improved understanding of the 
pathogenesis, treatment and outcome of ALF in children which would serve to identify factors 
that would help to predict the likelihood of death or need for liver transplantation (1). One aim of 
the PALF study is to develop better methods than currently exist to predict outcomes by 
identifying factors to predict spontaneous survival, i.e., survival without liver transplantation. 
The PALF study created a database of a cohort of 986 children that included demographic, 
clinical, and laboratory data and short-term outcomes. As an observational study, all measures 
and treatment were performed as standard of care at each of the participating centers. Clinical 
and laboratory data were collected for the first 7 days following study enrollment or until one of 
the events, death, transplantation, or discharge occurred within 21 days of study entry. 
1.3 GROWTH MIXTURE MODELS IN PALF STUDY 
Since etiology is so often unknown in PALF, it is of interest to identify patients with distinctive 
clinical patterns which are associated with different prognostics and outcomes. Mixture modeling 
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explores the data structure for detecting the homogeneous subgroups from a heterogeneous 
population. In the case of a heterogeneous population, mixture modeling is able to determine the 
probability of each participant’s belonging to a particular subgroup. Growth Mixture Models 
(GMM) developed by Muthen and his colleagues (3, 4, 5) provided a method to detect 
heterogeneity through growth trajectory patterns by finding distinctive patterns. 
In this paper, we apply growth mixture modeling method to the PALF cohort data. We 
classify the PALF patients based on the patterns of changes in the International Normalized 
Ratio (INR), which is a biomarker of liver function measuring hepatic-based coagulopathy. 
Higher values of INR mean that blood is taking more time to coagulate or clot. INR is an 
important biomarker for deciding upon listing a patient for liver transplantation (6). The major 
aim in this paper is to group PALF patients based on their INR trajectory in the first 7 days after 
enrollment to the study and examine whether the subgroups distinguish the participants who 
survive without liver transplantation from the ones who die without such a procedure. In 
addition, categorizing participants into distinctive patterns of disease progression may lead to 
better understanding of indeterminate patients, or expanding definitions of existing diagnoses, 
and to enable more precise insight of PALF. 
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2.0  DATA AND METHODS 
2.1 GROWTH MIXTURE MODELING AND INFERENCE 
We use some notations from Muthen (3). In a longitudinal design the response variables yi are 
continuous observed variables (yi1, yi2,…, yiT ) for individual i with i = 1, …, N, at potential T 
time points ti1,…, tiT. In growth mixture modeling, we explore the relationship of the response 
variables to two different kinds of latent variables. The first kind is an M-dimensional vector of 
latent continuous growth variables Ƞi = ( Mii ηη ,...,1 )
T in individual i representing the random 
effects regarding intercepts and slopes.  The second kind is a K-dimensional latent categorical 
variables (also called latent class variables),  ci = (ci1,…, ciK)T where cik=1 or zero depending on 
whether the individual i belongs to class k for k = 1, …, K. 
In mixture model analysis, models with different numbers of latent classes are explored 
and compared in terms of fit for the best number of classes. For K latent classes, let πi=(πi1, 
πi2,…, πiK)
T be the probability vector associated with ci, where πik, equal to P (cik=1), denotes the 
probability of the individual i belonging to the class k and  =1. 
For individual i, without any covariate, the logit model for  is expressed as                            
                      (1) 
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where the class K is a reference class, is a ( K -1) parameter vector, and  is modeled by a 
multinomial logit regression as unordered categorical outcomes. 
The latent class variable is incorporated in the growth mixture model by letting each 
individual’s intercept and slope vary.  The distributions of these intercepts and slopes are 
determined by their class membership. The expression of yi related to the continuous latent 
variable Ƞi for individual i in the mixture model framework is   
                  yi = Λy Ƞi  +  εi              (2) 
where Λy is a T x M design matrix; Ƞi is affected by the membership of the latent class variable 
which identifies the individual i into one of K classes,       
     Ƞi =Wci + ζi              (3) 
where W is an M x K matrix containing columns ωk as class-specific parameters for each class 
representing the mean of [Ƞi | ci] , for k = 1,…,K, without any covariate adjustment. The 
distribution of residual vector εi is N (0, Θ) with Θ a diagonal covariance matrix, and the 
distribution of residual vector ζi 
is N (0, Ωk) accounting for the class-specific feature, with 
assuming εi and ζi uncorrelated to each other. Given latent class variable ci, the conditional 
distribution [yi | ci ]  follows NT (Λy Wci,  Λy Ωk Λy` + Θ). 
Growth mixture modeling explains unobserved heterogeneity among subjects in their 
longitudinal progress using both random effects (7) and finite mixtures (8) by allowing separate 
sets of parameters for mixture components. In mixture modeling, parameters are estimated by the 
method of maximum likelihood (e.g., EM algorithm). The growth mixture modeling techniques 
were implemented with the Mplus program (9). 
Methods for fitting GMM have been demonstrated elsewhere (3, 9). A brief description 
of model fitting is summarized here. GMM applies the EM algorithm by treating the continuous 
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latent variables Ƞi and the categorical latent class variables ci as missing data. We can write the 
complete-data log-likelihood for the individual i  as follows ([x] denotes a density or distribution 
of a random variable vector x). 
  ci] + log[Ƞi |ci] + log[yi|Ƞi])            (4) 
where             
     ci ] )=                    (5) 
and [Ƞi | ci ] is assumed to follow the normal distribution NM (Wci,  Ωk) and [ yi | Ƞi] is assumed 
to follow the normal distribution NT (Λy Ƞi, Θ) ,  NB(z) representing  the normal distribution for 
a B-dimensional normal vector z. 
In E-step, to maximize the expectation of the complete-data log likelihood in model (4) 
with respect to the missing data, given the response observations yi ,  ci can be written as    
 yi ) =  NT (Λy Wci,  Λy Ωk Λy` + Θ) /   NT (Λy Wci,  Λy Ωk Λy` + Θ)        (6) 
Model (6) represents the posterior probability pik for the latent class variables cik. 
Repetition of the E-steps and M-steps continues until convergence is reached. To achieve 
the global maximum, several different starting values were employed in the final model. 
2.2 STUDY DESIGN, SAMPLE AND OUTCOME 
2.2.1 Study Design and Sample 
The PALF Study Group (PALFSG) is a multi-center and multi-national collaborative study 
consisting of 24 sites from the United States (21 sites), Canada (1 site) and the United Kingdom 
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(2 sites), that developed a dataset to facilitate and improve understanding of the pathogenesis, 
treatment and outcome of acute liver failure in infants, children, and adolescents. Participants 
through 17 years of age were eligible for the PALF study if they met the following entry criteria : 
1) no known evidence of chronic liver disease; 2) biochemical evidence of acute liver injury; 3) 
hepatic-based coagulopathy defined as a prothrombin time (PT) was betweent 15.0-19.9 seconds 
or INR  was between 1.50-1.99 not corrected by vitamin K in the presence of clinical hepatic 
encephalopathy (HE) or PT at least 20 seconds or INR at least 2.0, regardless of the presence or 
absence of clinical HE. PT is an alternative test to INR for liver coagulopathy, but the result of 
the PT test depends on the method used so that there is variability among the laboratories of the 
participating centers. HE is defined as a disturbance in central nervous system function because 
of hepatic insufficiency. The screening for eligibility was performed prior to any plasma therapy 
and no more than 72 hours prior to enrollment in the PALF study. Following informed consent 
from a parent or legal guardian, demographic, clinical and laboratory information were recorded 
daily for the first 7 days from enrollment into the PALF study or until the occurrence of death, 
liver transplantation, or discharge within 7 days. A final diagnosis was determined for each 
participant by the primary investigator at the clinical site. The primary outcome was determined 
at 3 weeks (21 days) after entry into the study as the earliest of the following events: death 
without transplantation, transplantation and survival without transplantation. 
As of July 2011, there were 986 participants in the PALF database. INR values were used 
in this paper as the longitudinal assessments of a patient’s clinical severity, with higher values 
indicating worse hepatic coagulopathy. One site from the United Kingdom, which measured 
hepatic-based coagulopathy by PT instead of INR, was excluded from the analysis. The 
remaining 23 sites had 914 patients. There were another 30 patients for whom INR values were 
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not collected so these participants were excluded. This resulted in 884 participants with at least 
one INR measured in the first 7 days after study enrollment.  In PALF, eligibility regarding INR 
or PT were performed between 72 hours prior to enrollment and up to enrollment, however, the 
actual INR/PT values used for eligibility were not recorded in the PALF database, which means 
that there are some participants whose INR levels were always below 1.5 following enrollment. 
Since this was an observational study, INR may not have been collected due to limitations in 
drawing blood or physician’s judgment. 
2.2.2 Outcome Measure 
INR is used to measure the speed of a particular pathway of coagulation, comparing it to the 
normal condition. With a heavily damaged liver, the INR increases with the synthesis of vitamin-
K dependent coagulation factor getting impaired. The coagulopathy of participants in PALF 
cannot be corrected by vitamin K as that is an exclusion criterion. INR was designed to be 
collected daily for the first 7 days from enrollment if PALF participants stayed in the hospital 
before transplantation.  As shown in Figure 1, the INR  collected during the first 7 days averaged 
3.34, 2.94, 2.72, 2.72, 2.59, 2.59, 2.49, depicting a trend of decline in the first 3 days followed by 
a relatively flat trajectory in the next 4 days. 
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2.3 GROWTH MIXTURE MODEL FOR INR MODELING 
The aim of using GMM was to examine whether variability in change of INR up to 7 days can be 
captured by identifying patterns of trajectories from their distinctive natural progress. The time 
course of change in INR during the first 7 days into PALF was modeled in the 884 participants 
with at least one INR measured. As it was our aim to classify PALF patients based on INR 
trajectory patterns only, no covariate was included in the growth mixture models. To establish 
the best classification and most interpretable solutions based on the longitudinal pattern of INR 
trajectory, we fit a series of growth mixture models allowing both linear and quadratic 
trajectories. However, these growth models did not provide adequate fits due to a more rapid 
change rate from day 1 to day 3 than from day 4 to day 7 in a portion of the PALF patients as 
shown in Figure 1. Thus, piecewise models were applied to separate time periods, with distinct 
growth curves by transition points.  Piecewise models allow flexible shapes with straight or 
curved trajectories between the transition points to improve the local fit (10, 12). Two-piece 
growth mixture models were discovered to better fit the observed data than the models with 
simple linear and quadratic trends.  The two periods were the first 3 days and the next 4 days 
with linear trend over the first period and the quadratic curve in the second period.  This was 
determined by the observed data. 
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To explicitly express model (2), we have       
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where represents INR status for individual i at the entry of study;  represents the linear 
slope of growth trajectory for individual i in the first time-period; denotes the linear slope of 
growth trajectory for individual i in the second time-period; denotes the quadratic slope of 
growth trajectory for individual i in the second time-period. 
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To incorporate the latent class by letting the individual intercepts and slopes vary as 
functions of the membership of latent class, with a 3-class model, model (3) was written as 
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If a participant was in class 1, the first column ω1 = (  is the class-
specific parameters to capture the features of trajectory for INR developmental pattern for the 
participants in class 1. Similarly, ω2 = (   
class-specific parameters for the participant s in class 2 and class 3 respectively. 
To keep the model identifiable, the variance-covariance matrix was assumed to be class 
invariant. i.e., the class-specific features of the residuals are assumed to be similar. Furthermore, 
we assumed that the correlations only existed between the intercept and the linear slope over the 
first time-period, as well as between the linear slope over the first time-period and the linear 
slope over the second time-period;   was class-invariant across the 3 classes with normal 
distribution of mean 0 and variance-covariance matrix 


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The proposed 3-class model described above is given graphically in Figure 2. 
2.4 GROWTH MIXTURE MODEL SELECTION 
There are several criteria to evaluate the fit of growth mixture models. The Bayesian Information 
Criterion (BIC) measures how adequately the model describes the data without too many 
parameters. BIC calculates the maximized likelihood with a penalty for overfiting due to adding 
parameters in the model. A smaller value indicates a better fit (12). An alternative to BIC, the 
Akaike Information Criterion (AIC) has been shown to overestimate the number of components 
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from finite mixture models such that the BIC consistently outperforms AIC by picking the 
correct model (13). The simulations to decide the number of classes in growth mixture modeling 
proved superiority of BIC to AIC by correctly indicating the correct numbers across different 
kinds of models and different sample sizes (14).  The Lo-Mendell-Rubin likelihood ratio test is 
specifically used for mixture models to compare the likelihood between the model with K classes 
and the model with K-1 classes. A p-value less than 0.05 is considered to favor the K-class 
model significantly over the K-1 class model (14, 15). In addition, entropy values are calculated 
for models with more than one class, to evaluate the accuracy and uncertainty of classification of 
individuals into latent classes. Entropy values range from 0 to 1, with 0 indicating complete 
randomness and 1 is prefect classification (16). To prevent overfitting in mixture modeling, a 
latent class including a very small fraction of individuals is not recommended (17). 
2.5 MISSING DATA 
Missing data data are a challenge in the PALF study due to early occurrence of outcome (prior to 
7 days in the study), or lack of a blood draw to obtain INR which may be due to investigator’s 
judgment not to measure INR on a certain day. Of the 377 PALF patients who died, underwent 
transplantation or were discharged prior to 7 days, 28.3% had at least one INR measure missing 
during their hospitalization; whereas among the 507 patients who stayed in the study for at least 
7 days, 35.5% had at least one missing INR. M-plus (9) conducts maximum likelihood 
estimation for datasets containing missing data without the need to impute missing values and 
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provides unbiased estimates under the relatively unrestrictive missing at random (MAR) 
assumption (18). We assumed missing at random for INR among PALF patients in the analyses. 
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3.0  RESULTS 
3.1 STUDY SAMPLE 
Among the 884 participants,  389 (44.0%) had an unknown etiology, diagnosis as indeterminate, 
while the remaining 495 participants had a specified final diagnosis with 116 (13.1%) as 
acetaminophen toxicity, 82 (9.3%) as metabolic disease, 61 (6.9%) as autoimmune hepatitis, 66 
(7.5%) as viral infection hepatitis, 170 (19.2%) as other miscellaneous specified diagnoses 
including hemophagocytic syndrome, shock/ischemia, drug-induced hepatitis.  Compared to the 
participants with a specified final diagnosis, the participants with an indeterminate final 
diagnosis were on average younger at enrollment, more likely to be male, and more likely to 
have hepatic encephalopathy at enrollment. The clinical lab tests at enrollment reflected the 
indeterminate participants having worse liver function with significantly higher total bilirubin 
and INR than the participants with a specified diagnosis.  A participant with an indeterminate 
final diagnosis had a higher probability of undergoing liver transplantation than those with a 
specified diagnosis within the first 3 weeks from enrollment (Table 1). 
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3.2 NUMBER OF LATENT CLASSES 
Exploring models with different numbers of classes suggested that PALF patients were not 
homogeneous in terms of change in INR (Table 2). The 3-class piecewise GMM was favored 
over both the single-class and the 2-class piecewise models using the Lo-Mendell-Rubin 
likelihood ratio test. BIC results consistently favored the 3-class piecewise model. The 4-class 
model provided a marginal improvement in the Lo-Mendell-Rubin likelihood ratio test (p=0.04) 
over the 3-class model, but indicated a worse quality of classification (entropy=0.89 for the 3-
class model vs. entropy=0.81 for the 4-class model). The 5-class model provided no advantage 
over the 4-class model based on the Lo-Mendell-Rubin likelihood ratio test (p=0.10). Finally, the 
3-class model was chosen as the final model as each subgroup contained a reasonable proportion 
of participants whereas the 4-class model might cause overfitting as it contained a subgroup with 
less than 10% of participants. 
3.3 CLASSIFICATIONS FROM A 3-CLASS MODEL 
The time course of change in INR during the first 7 days after enrolling in the PALF study was 
modeled in the 884 PALF participants with at least one INR measured. The 3-class model 
classified the participants into subgroups which we labeled as high-INR with 91 (10.3%) 
participants, middle-INR with 307 (34.7%) participants and low-INR with 486 (55.0%) 
participants. The observed and the estimated means of INR in the three groups from the 3-class 
model are given in Figure 3. The mean INR in the high-INR group was 7.26 at enrollment 
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followed by a rapid decline to 6.38 on day 3, then rebounding back to 6.70 on day 4 and day 5. It 
then decreased to 6.28 and 5.50 on day 6 and day 7.  The mean INR in the middle-INR group 
started at 3.62, and decreased to 3.05 on day 3, then stayed at a stable level at 3.02 until the end 
of 7 days. The mean INR in the low-INR group was 2.32 at enrollment with moderate decrease 
to 1.81 on day 3, and then declined during the last 4 days to 1.57 on day 7. 
Table 3 provides some information regarding the associations of the class membership 
based on the fitted 3-class model with diagnoses of different comorbidities.  The participants 
with indeterminate diagnosis were most likely to belong to the high-INR group and least likely to 
belong to the low-INR group as compared to the participants with a specified diagnosis 
(p<0.0001).  The association of 3 latent class groups was significant (p<0.0001) with the study 
endpoint of the earliest event from death without transplantation, transplantation and survival 
without transplantation (Table 4). In the high-INR group, 19% died without transplantation, 61% 
received transplantation and 20% survived with native liver without transplantation. In the 
middle-INR group, 17% died, 46% received transplantation and 37% survived with native liver. 
In the low-INR group, 7% of the participants died,   13% received liver transplantation and 79% 
survived with native liver without transplantation. The mortality rates without liver 
transplantation within 21 days were similar (p=0.70) in the high-INR group (19%) and in the 
middle-INR group (17%), whereas the rate of transplantation was significantly higher (p=0.01) 
the high-INR group (61%) than those in the middle-INR group (46%), which remained 
significant after adjustment for multiple comparisons with Bonferroni correction. 
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4.0  DISCUSSION 
The exploration of the INR trajectory showed important heterogeneity in the temporal pattern of 
change over first 7 days following enrollment in PALF participants. PALF participants have 
rapid onset of disease, severe progress and uncertain prognosis, with substantial mortality and 
high probability of liver transplantation. The aim in this study was to discover methods and 
identify participants who have a high likelihood of surviving without transplantation from those 
who are unlikely to survive without transplantation based on INR. We found that modeling with 
GMM can provide potential useful information. Using a GMM model to identify distinctive 
growth trajectories, we classified the PALF participants into 3 subgroups (latent classes) 
according to INR trajectory.  The configuration including the starting INR level with INR’s 
change in the first week for each latent class provided an insight of how INR progressed 
quantitatively. There was similar mortality without live transplantation between the model-
identified high-INR group and the middle-INR group, but the rate of transplantation was much 
higher in the high-INR group than in the middle-INR group which indicated that INR served as a 
factor in deciding whether the participant should undergo liver transplantation    This result 
provides the clinical investigators a second thought on whether INR level should be a pivotal 
indicator for determining a liver transplantation. The indeterminate patients were more likely to 
be classified into the high INR group than those with a specific diagnosis and more likely to 
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undergo liver transplantation. This may suggest that we need a more comprehensive evaluation 
to clearly delineate decision making regarding liver transplantation. Further work will focus on 
exploration of trajectories of other important clinical biomarkers, e.g. total bilirubin or hepatic 
encephalopathy, and their association with outcomes. We need to establish a comprehensive 
assessment to evaluate the severity of disease among indeterminate patients and to accurately 
predict the possibility of hepatic recovery with native liver to prevent from unnecessary liver 
transplantation. 
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APPENDIX A- TABLES 
Table 1. Characteristics of PALF Participants by Diagnosis 
 Participants with a 
specified diagnosis 
 
N=495 
Participants with 
indeterminate 
diagnosis 
N=389 
P-value from 
either Wilcoxon 
or χ2 test 
 N (%) N (%)  
Age at enrollment (year) 
    Median 
    Range 
 
    Less than 1 yr  
    1-2 yrs old 
    3-9 yrs old 
    Greater than 10 yrs 
 
7.0 
0.0, 18.0 
 
143 (28.9) 
48 (9.7) 
89 (18.0) 
215 (43.4) 
 
4.2 
0.0, 17.9 
 
85 (21.9) 
71 (18.3) 
139 (35.7) 
94 (24.2) 
 
0.002 
 
 
<0.0001 
Sex 
    Male 
 
219 (44.2) 
 
227 (58.4) 
 
<0.0001 
Encephalopathy at enrollment 
    Missing 
    No 
    Yes 
 
33 
247 (53.4) 
216 (46.7) 
 
19 
168 (45.3) 
203 (54.7) 
 
0.02 
Total bilirubin at enrollment 
(mg/dl) 
        N 
        Median 
        Range 
 
 
412 
5.1 
0.3, 59.8 
 
 
334 
13.9 
0.1, 40.9 
 
<0.0001 
 
AST at enrollment (Aspartate 
transaminase IU/L)  
        N 
        Median 
        Range 
 
 
454 
1666.5 
4.0, 46311.0 
 
 
358 
2052.5 
       19.0, 32040.0 
 
0.06 
Albumin at enrollment (mg/dl) 
        N 
        Median 
        Range 
 
448 
2.8 
0.6, 4.9 
 
357 
2.9 
1.1, 4.5 
 
0.29 
INR at enrollment 
         N 
         Median 
         Range 
 
459 
2.5 
1.0, 14.9 
 
368 
2.8 
1.0, 26.4 
 
0.002 
21-day outcome 
Died without transplantation 
Transplantation 
Survival without transplantation 
 
66 (13.3) 
89 (18.0) 
340 (68.7) 
 
39 (10.0) 
174 (44.9) 
176 (45.1) 
 
<0.0001 
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Table 2. Model Fit Criteria for Different Models 
Model # of 
classes 
BIC Entropy p-value 
from Lo-
Mendell-
Rubin tests 
Proportion of subjects in class 
1 2 3 4 5 
Linear 
GMM 
         
1-class 
model 
1 18407.26   
.000 
    
2-class 
model 
2 13332.36 0.91 <0.0001 
.249 .751 
   
3-class 
model 
3 12127.40 0.87 0.0003 
.122 .407 .471 
  
4-class 
model 
4 11804.78 0.83 0.006 
.061 .197 .350 .392 
 
5-class 
model 
5 11897.11 0.77 0.06 
.050 .144 .261 .265 .281 
Quadratic 
GMM 
         
1-class 
model 
1 18193.25   
.000 
    
2-class 
model 
2 12927.70 0.91 <0.0001 
.271 .729 
   
3-class 
model 
3 11734.22 0.88 0.03 
.118 .376 .506 
  
4-class 
model 
4 11460.68 0.81 0.06 
.080 .258 .317 .344 
 
5-class 
model 
5 1162.53 0.78 0.16 
.052 .143 .232 .267 .306 
2-
piecewise 
GMM 
         
1-class 
model 
1 18285.88   
.000 
    
2-class 
model 
2 12905.89 0.91 <0.0001 
.298 .702 
   
3-class 
model 
3 11699.36 0.89 0.0003 
.103 .347 .550 
  
4-class 
model 
4 11479.74 0.81 0.04 
.071 .272 .318 .338 
 
5-class 
model 
5 11620.17 0.77 0.10 
.051 .146 .237 .254 .312 
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Table 3. Association of 3 Latent Class Groups from 3-class Model with Diagnosis 
Diagnosis  
 
High INR group  
 
Middle INR group    Low INR group  
 
Total  
 
Acetaminophen toxicity  
N 
(column percentage) 
(row percentage) 
 
6  
(6.6)  
(5.2) 
 
27  
(8.8)  
(23.3) 
 
83  
(17.1)  
(71.1) 
 
116 
 
(13.1)  
Metabolic disease  
N 
(column percentage) 
(row percentage) 
 
6  
(6.6)  
(7.3 ) 
 
8  
(9.1)  
(34.2) 
 
48  
(9.9)  
(58.5) 
 
82  
(9.3)  
Autoimmune hepatitis 
N 
(column percentage) 
(row percentage) 
 
2 
(2.2) 
(3.3)  
 
10  
(3.3)  
(16.4) 
 
49  
(10.1)  
(80.3) 
 
61  
(6.9)  
Viral infection hepatitis  
N 
(column percentage) 
(row percentage) 
 
9  
(9.9)  
(13.6) 
 
23  
(7.5)  
(34.9) 
 
34  
(7.0)  
(51.5) 
 
66  
(7.5)  
Other specified diagnosis  
N 
(column percentage) 
(row percentage) 
 
8 
(8.8)  
(4.7) 
 
57 
 (18.6)  
(33.5) 
 
105  
(21.6)  
(61.8) 
 
170  
(19.2)  
Indeterminate  
N 
(column percentage) 
(row percentage) 
 
60  
(65.9)  
(15.4) 
 
162  
(52.8)  
(41.7) 
 
167 
(34.4)  
(42.9) 
 
389  
(44.0)  
Total 
N 
(row percentage) 
 
91 
(10.3) 
 
307 
(34.7) 
 
486 
(55.0) 
 
884 
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Table 4. Association of 3 Latent Class Groups from 3-class Model with 21-day Outcome 
21-day outcome  High INR group  
n=91 
N (%#)  
Middle INR group  
n=307  
N (%#)  
Low INR group  
n=486  
N (%#)  
Death without LT a 17 (19%)  52 (17%)  36 (7%)  
LT b 56 (61%)  142 (46%)  65 (13%)  
Survival without LT  18 (20%)  113 (37%)  384 (79%)  
 
LT = Liver Transplantation 
 
a P-value from chi-square test to compare death without LT between high INR group (19%) and 
middle INR group (17%) was 0.70.  
 
b P-value from chi-square test to compare LT between high INR group (61%) and middle INR 
group (46%) was 0.01.  
 
# % represents column percentage 
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APPENDIX B- FIGURES 
 
Figure 1. Means of INR and 95% Confidence Interval in the First 7 Days  
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Figure 2. Diagram of 3-class, 2-piecewise GMM without Covariate for INR 
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Figure 3.  Sample Means And Estimated Means from the fitted 3-class Model 
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